?The pharma firm has two USFDA-inspected research and development (R&D) faci .. nnRead more at: nhttps://health.economictimes.indiatimes.com/news/pharma/financial-performance/pharma-formulation-firm-rubicon-research-files-draft-papers-for-rs-1085-cr-ipo/112219042?utm_source=category_listing&utm_medium=sectionListing
Rubicon Generic Tranexamic Acid Receives Approval in US
Enforcement Report - Week of June 5, 2024
Rubicon's Generic Carbidopa; Levodopa Receives Approval in US
Enforcement Report - Week of May 15, 2024
Rubicon's Generic Nortriptyline Hydrochloride Receives Approval in US
Rubicon's Generic Lithium Citrate Receives Approval in the U.S.
Rubicon's Generic Potassium Chloride Receives Approval in the U.S.
Rubicon's Generic Diclofenac Sodium Receives Receives Approval in the U.S.
Rubicon Research Generic Amitriptyline HCL Receives Approval in the U.S.A